The commercial health insurance company - KKH (hereinafter KKH) pursues the goal of concluding discount contracts with all suitable pharmaceutical companies in accordance with § 130a paragraph 8 SGB V for the active substance/active substances within the framework of a so-called “open-house procedure”. Under the specification of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a discount agreement pursuant to § 130a (8) of the German Civil Code V. to the aforementioned active substance. Interested pharmaceutical companies can request participation documents and the contract from the contact address mentioned in l.1.

The commercial health insurance company - KKH (hereinafter KKH) pursues the goal of concluding discount contracts with all suitable pharmaceutical companies in accordance with § 130a paragraph 8 of the SGB V for the following active substances (ATC) and, if necessary, limiting certain dosage forms within the framework of a so-called “open-house procedure”:

1. Methylhenidate only HVW in pack sizes not equal to 50 pieces (N06BA05)

Providing uniform contractual terms and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or entry to a discount contract in accordance with Section 130a (8) SGB V for the above-mentioned active ingredient. Interested pharmaceutical companies can contact l.1. Request the participation documents and the contract from the contact address given. A precondition for the conclusion of a contract is that the interested pharmaceutical company has completed and signed the requested participation documents. A contract is concluded with every pharmaceutical company that meets the eligibility requirements. There is no exclusivity. The accession or the conclusion of the contract can take place at any time and under the same conditions. Individual contract negotiations are not carried out. Should the KKH carry out a tender for exclusive contracts in the form of the open procedure during the contract period for the active substances, the contracts concluded as part of this publication will be terminated in accordance with the contractual regulations.